Entropy Neurodynamics Limited Entropy Neurodynamics Limited

Entropy Neurodynamics Limited

ENP

Classifica tra le azioni #26188
Entropy Neurodynamics Limited operates as a clinical-stage pharmaceutical... Entropy Neurodynamics Limited operates as a clinical-stage pharmaceutical company, dedicated to pioneering novel formulations for psilocin administration. These formulations are intended for use alongside psychotherapy, aiming to tackle medical conditions with pressing unmet needs across Australia, Canada, Switzerland, and the United States. The firm's flagship development is TRP-8803, an intravenously infused psilocin formulation that has successfully concluded Phase 2 clinical trials. These trials investigated its potential to treat binge eating disorder, fibromyalgia, irritable bowel syndrome, abdominal pain, and visceral tenderness. Additionally, the company is advancing TRP-8802, a synthetic, orally administered psilocybin compound. TRP-8802 is currently undergoing Phase 2a clinical trials for binge eating and is in Phase 2 clinical development for fibromyalgia and irritable bowel syndrome. Established in 2019 and headquartered in Camberwell, Australia, the company adopted its current name, Entropy Neurodynamics Limited, in November 2025, having previously operated as Tryptamine Therapeutics Limited.
Prezzo delle azioni
$0.02468497
Ultima sincronizzazione: 2026-07-30
Capitalizzazione di mercato
$40.28M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-56.08%
Paese
AU
Scambia Entropy Neurodynamics Limited (ENP)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per Entropy Neurodynamics Limited (ENP)
L’azione Entropy Neurodynamics Limited (simbolo: ENP) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Oct 19, 2026.
Una quota di ENP acquistata prima di Oct 19, 2026 equivale oggi a 0 quote di ENP.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL